Combination of the Hypercvad Regimen with Dasatinib Is Effective in Patients with Relapsed Philadelphia Chromosome (Ph) Positive Acute Lymphoblastic Leukemia (ALL) and Lymphoid Blast Phase Chronic Myeloid Leukemia (CML-LB).

被引：25
|
作者：
Ravandi, Farhad
Kantarjian, Hagop M.
Cortes, Jorge
Thomas, Deborah A.
Faderl, Stefan
Jones, Dan
Jabbour, Elias [1 ]
Koller, Charles
Dara, Samuel [1 ]
Garris, Rebecca
Kebriaei, Partow
Borthakur, Gautam
Ferrajoli, Alessandra
O'Brien, Susan
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
10.1182/blood.V114.22.636.636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：806 / 807
页数：2
相关论文
共 50 条
  • [41] Impact of Polymorphisms in Pharmacokinetic Genes on Tyrosine Kinase Inhibitor (TKI) Tolerability in Patients with Chronic Myeloid Leukemia (CML) or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Patel, Jai N.
    Lopes, Karine Eboli
    Druhan, Lawrence J.
    Zeng, Hang
    Beam, Travis
    Moore, Donald C.
    Salem, Ahmed
    Hamadeh, Issam
    Savage, Quanisha
    Chojecki, Aleksander L.
    Ai, Jing
    Knight, Thomas G.
    Ragon, Brittany Knick
    Shah, Nilay A.
    Sanikommu, Srinivasa Reddy
    Steuerwald, Nury M.
    Smith, Mathew
    Hamilton, Alicia
    Rangavajhula, Keerthana
    Bell, Ariel
    Drummond, Kendra
    Symanowski, James T.
    Grunwald, Michael R.
    BLOOD, 2022, 140 : 11530 - 11531
  • [42] PONATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKEMIA AND PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Narayanan, V.
    Pollyea, D. A.
    Gutman, J. A.
    Jimeno, A.
    DRUGS OF TODAY, 2013, 49 (04) : 261 - 269
  • [43] Pharmacokinetics of Nilotinib in Pediatric Patients with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia
    Hijiya, Nobuko
    Zwaan, C. Michel
    Rizzari, Carmelo
    Foa, Robin
    Abbink, Floor
    Lancaster, Donna
    Landman-Parker, Judith
    Millot, Frederic
    Moppett, John
    Nelken, Brigitte
    Putti, Maria Caterina
    Tian, Xianbin
    Sinclair, Karen
    Santanastasio, Helene
    Buchbinder, Aby
    Kearns, Pamela
    CLINICAL CANCER RESEARCH, 2020, 26 (04) : 812 - 820
  • [44] A phase 2 study of the combination of decitabine (DAC), venetoclax (VEN), and ponatinib in patients (Pts) with chronic myeloid leukemia (CML) in accelerated phase (AP)/myeloid blast phase (MBP) or Philadelphia-chromosome positive (Ph plus ) acute myeloid leukemia (AML)
    Senapati, Jayastu
    Ravandi, Farhad
    Dinardo, Courtney Denton
    Issa, Ghayas C.
    Sasaki, Koji
    Konopleva, Marina
    Macaron, Walid
    Nasr, Lewis Fady
    Zoghbi, Marianne
    Nasnas, Cedric Christophe
    Pemmaraju, Naveen
    Chien, Kelly Sharon
    Ohanian, Maro
    Jabbour, Elias
    Maiti, Abhishek
    Kantarjian, Hagop M.
    Short, Nicholas James
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Cerchione, Claudio
    Locatelli, Franco
    Martinelli, Giovanni
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Venetoclax (VEN) and tyrosine kinase inhibitor (TKI) combinations in Philadelphia chromosome-positive (Ph plus ) acute myeloid leukemia (AML) and chronic myeloid leukemia myeloid blast phase (CML MBP).
    Maiti, Abhishek
    Ravandi, Farhad
    Cortes, Jorge E.
    Jabbour, Elias
    Marx, Kayleigh
    Daver, Naval Guastad
    Garcia-Manero, Guillermo
    Konopleva, Marina
    Benton, Christopher Brent
    Masarova, Lucia
    Dinardo, Courtney Denton
    Bose, Prithviraj
    Naqvi, Kiran
    Pierce, Sherry A.
    Kantarjian, Hagop M.
    Short, Nicholas James
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Long-Term Follow-up of Combined Hypercvad (hCVAD) Regimen with Dasatinib (Db) in the Front Line Therapy of Patients (pts) with Philadelphia Chromosome Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Lee, Hun Ju
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Faderl, Stefan
    Koller, Charles
    Ferrajoli, Alessandra
    Jabbour, Elias
    Garris, Rebecca
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Wierda, William G.
    Burger, Jan A.
    Cortes, Jorge E.
    O'Brien, Susan
    Ravandi, Farhad
    BLOOD, 2011, 118 (21) : 655 - 656
  • [48] Olverembatinib (HQP1351) Overcomes Ponatinib Resistance in Patients with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Jabbour, Elias
    Koller, Paul B.
    Oehler, Vivian G.
    Jamy, Omer H.
    Mukherjee, Sudipto
    Hunter, Anthony M.
    Baer, Maria R.
    Beck, Joseph T.
    Chen, Zi
    Guo, Huanshan
    Fu, Lei
    Men, Lichuang
    Wang, Hengbang
    Yang, Dajun
    Zhai, Yifan
    Kantarjian, Hagop
    Jiang, Lixin
    Wang, Cunlin
    BLOOD, 2022, 140
  • [49] Efficacy and Safety of Ponatinib in Patients with Accelerated Phase or Blast Phase Chronic Myeloid Leukemia (AP-CML or BP-CML) or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): 12-Month Follow-up of the PACE Trial
    Kantarjian, Hagop M.
    Kim, Dong-Wook
    Pinilla-Ibarz, Javier
    le Coutre, Philipp
    Paquette, Ronald
    Chuah, Charles
    Nicolini, Franck E.
    Apperley, Jane
    Khoury, H. Jean
    Talpaz, Moshe
    DiPersio, John F.
    DeAngelo, Daniel
    Abruzzese, Elisabetta
    Rea, Delphine
    Baccarani, Michele
    Muller, Martin C.
    Gambacorti-Passerini, Carlo
    Wong, Stephane
    Lustgarten, Stephanie
    Rivera, Victor M.
    Clackson, Tim
    Turner, Christopher D.
    Haluska, Frank G.
    Guilhot, Francois
    Deininger, Michael W.
    Hochhaus, Andreas
    Hughes, Timothy P.
    Goldman, John
    Shah, Neil
    Cortes, Jorge E.
    BLOOD, 2012, 120 (21)
  • [50] Response to imatinib in patients with chronic myeloid Leukemia (CML) with variant Philadelphia chromosome (Ph).
    El-Zimaity, MMT
    Kantarjian, HM
    Talpaz, M
    Garcia-Manero, G
    O'Brien, S
    Giles, FJ
    Verstovsek, S
    Ferrajoli, A
    Rios, MB
    Hayes, KJ
    Cortes, JE
    BLOOD, 2002, 100 (11) : 788A - 788A
12345